North land pharmaceutical industry in the medium term net profit of 2260 Yuan Rose 33%

NetEase Finance August 4 News North Land pharmaceutical Industry released 2010.5 annual report in late Wednesday. In the first half of 2010, total operating income of the North Land pharmaceutical industry was 109 million yuan, down 7.29% from a year earlier.　　The total operating profit and gross profit increased by 26.72% and 27.4% respectively in the same period, the net profit of the shareholders of the listed companies was 2260.15 yuan, the increase was 32.94%, and the earnings per share was 0.22 yuan, down 33.33%. The North land pharmaceutical Industry said that this report period of 0.22 yuan per share, 0.33 lower than a year earlier, 33.33%, mainly the company in October 2009, the public issue of 17 million shares, the implementation of the 2009 profit distribution scheme, with capital accumulation to increase equity 3,394 420,000 shares, The total share capital was increased by 5,094 to 420,000 shares over a year earlier. In addition, the company's total operating income is lower, mainly because the subsidiary drug distribution business income lower, resulting in the main business income from a year earlier decline.　　But the lower income of the subsidiary's drug distribution business did not have a significant impact on the company's profits. Semi-annual reports show that during the reporting period, the North Land pharmaceutical industry core products business and its structure has not undergone significant changes, pharmaceutical production business is still the core business.　　As a result of fund-raising investment, the reporting period of drug production and investment projects have different degrees of growth, sales revenue from the same period a year ago increased by 20.21%, drug production business gross profit margin than a year earlier Rose 1.32%.　　　　Profit distribution: The North land pharmaceutical Industry said that the reporting period, the company has no profit distribution and Capital Provident Fund to increase the stock plan. Related topics: Semi-annual report of 2010 listed Companies